Reviva Pharmaceuticals Holdings (RVPH) Accumulated Expenses (2021 - 2024)
Reviva Pharmaceuticals Holdings (RVPH) posted Accumulated Expenses of $6.72 million for Q4 2024, down 43.8% from $11.97 million a year earlier and down 8.7% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Accumulated Expenses (2021 - 2024) Analysis & Trends
Since Q1 2021, Reviva Pharmaceuticals Holdings has reported Accumulated Expenses for 16 quarters.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of 19.8% (FY2019 to FY2024).
- In prior years, Reviva Pharmaceuticals Holdings' Accumulated Expenses was $11.97 million in FY2023 (+114.5%), $5.58 million in FY2022 and $324,697 in FY2020 (-88.1%).
- The Q4 2024 figure stands as the lowest quarterly Accumulated Expenses since Q2 2023.
- On a year-over-year basis, Accumulated Expenses increased in six of the last eight quarters, with growth averaging 123.8%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q3 2023, with growth of 513.4%; the weakest was Q4 2024, with a decline of 43.8%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $7.36 million (Q3 2024), $7.3 million (Q2 2024) and $6.85 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Reviva Pharmaceuticals Holdings | 4.46 Mn | -82.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 6.72 Mn |
| Sep 30, 2024 | 7.36 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 6.85 Mn |
| Dec 31, 2023 | 11.97 Mn |
| Sep 30, 2023 | 7.53 Mn |
| Jun 30, 2023 | 6.34 Mn |
| Mar 31, 2023 | 3.03 Mn |
| Dec 31, 2022 | 5.58 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | 2.20 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 552,917.00 |
| Jun 30, 2021 | 804,485.00 |
| Mar 31, 2021 | 630,041.00 |
API Access
Reviva Pharmaceuticals Holdings Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();